HighField gains Chinese regulatory clearance to begin solid tumour therapy trial
HighField Biopharmaceuticals has received clearance for its investigational new drug (IND) application from the Center for Drug Evaluation (CDE) of…
Oncology
-
-
GSK’s lung cancer therapy gains EMA PRIME designation
GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) designation from the European Medicines Agency (EMA) for…
-
Lisata completes subject enrolment in multi-cancer trial of certepetide
Lisata Therapeutics has completed the enrolment of subjects for the Phase Ib/IIa CENDIFOX study to assess its investigational drug, certepetide,…
-
Daiichi Sankyo doses first subject in Phase III AML therapy trial
Daiichi Sankyo has announced the dosage of the first subject in the randomised Phase III QuANTUM-Wild trial of oral Vanflyta…
-
Arvinas and Pfizer’s combo therapy shows promise in breast cancer trial
Arvinas and Pfizer have shared preliminary outcomes from the Phase Ib segment of the TACTIVE-U sub-trial of vepdegestrant plus abemaciclib…
-
MSD’s trial of combination therapy for ovarian cancer meets primary endpoint
US-based pharmaceutical company MSD has published results from a Phase III trial of a potential combination therapy for ovarian cancer.…
-
Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application…
-
Medicus Pharma and Swanielle partner to expand BCC drug trial to Asia-Pacific
Canadian life sciences company Medicus Pharma has partnered with Japanese healthcare consultancy Swanielle to expand its Phase II clinical trial…
-
Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic…
-
Radiopharmaceutical trials face extra complexities due to nuclear red tape
The field of radiopharmaceuticals is growing rapidly, with a real buzz in oncology around emerging therapies. Radiopharmaceuticals are drugs that…
